Literature DB >> 26942573

Validation of the Modification of the Prolonged Papanicolaou Stain for the Diagnosis of Cervical Cancer.

Jeel Moya-Salazar1, Victor Rojas-Zumaran.   

Abstract

OBJECTIVES: To validate the modification of the prolonged Papanicolaou stain based on the quality control of time, units and staining stages (micro- and macroscopic), and on the stain reactivation based on the control. STUDY
DESIGN: A prospective study was performed on 125,358 cervical smears in Lima (Peru). The microscopic quality control included evaluating the cytological characteristics through the staining quality index (SQI) and the quality criteria for samples described by the Bethesda System (TBS). The macroscopic quality control is based on the interslide staining as a set corresponding to a poststaining vertical angle. The stains were reactivated with the addition of 0.15 and 2 g of phosphotungstic acid for Orange G and EA-50, respectively.
RESULTS: Both the nonneoplastic and the neoplastic findings comply with the quality criteria of the TBS (SQI value = 0.94). The yield per battery of staining fluctuated between 5,616 and 17,954 Pap smears, and the reactivation of stains produced a stain yield of up to four times the initial amount of the smears, saving USD 5,598.88 from 2013 to 2014.
CONCLUSION: The modification of prolonged Papanicolaou staining is an excellent alternative, with a cost-benefit ratio that generates savings and a higher yield per battery of staining.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26942573     DOI: 10.1159/000444117

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  2 in total

1.  Environmental Performance of Xylene, Hydrochloric Acid and Ammonia Solution During Pap Stain for Diagnosing Cervical Cancer.

Authors:  Jeel J Moya-Salazar; Victor A Rojas-Zumaran
Journal:  J Health Pollut       Date:  2016-09-13

2.  Cost and pollution by the use of xylene in cervical cytology in four Peruvian hospitals.

Authors:  Jeel Moya-Salazar; Richard Salazar-Hernández; Victor Rojas-Zumaran; Gloria Cruz-Gonzales; Hans Contreras-Pulache
Journal:  F1000Res       Date:  2021-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.